148 related articles for article (PubMed ID: 8428006)
1. Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation.
Fuse I; Mito M; Hattori A; Higuchi W; Shibata A; Ushikubi F; Okuma M; Yahata K
Blood; 1993 Feb; 81(4):994-1000. PubMed ID: 8428006
[TBL] [Abstract][Full Text] [Related]
2. Defective signal transduction through the thromboxane A2 receptor in a patient with a mild bleeding disorder: deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation.
Mitsui T; Yokoyama S; Shimizu Y; Katsuura M; Akiba K; Hayasaka K
Thromb Haemost; 1997 May; 77(5):991-5. PubMed ID: 9184416
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
5. Hemorrhagic thrombocytopathy with platelet thromboxane A2 receptor abnormality: defective signal transduction with normal binding activity.
Ushikubi F; Okuma M; Kanaji K; Sugiyama T; Ogorochi T; Narumiya S; Uchino H
Thromb Haemost; 1987 Apr; 57(2):158-64. PubMed ID: 2955539
[TBL] [Abstract][Full Text] [Related]
6. Pathogenetic analysis of five cases with a platelet disorder characterized by the absence of thromboxane A2 (TXA2)-induced platelet aggregation in spite of normal TXA2 binding activity.
Fuse I; Hattori A; Mito M; Higuchi W; Yahata K; Shibata A; Aizawa Y
Thromb Haemost; 1996 Dec; 76(6):1080-5. PubMed ID: 8972034
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the defective signal transduction mechanism through the platelet thromboxane A2 receptor in a patient with polycythemia vera.
Ushikubi F; Ishibashi T; Narumiya S; Okuma M
Thromb Haemost; 1992 Jan; 67(1):144-6. PubMed ID: 1535462
[TBL] [Abstract][Full Text] [Related]
8. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
9. [PI metabolism and Ca mobilization in patients with platelet dysfunction].
Fuse I; Hattori A; Higuchi W; Shibata A
Nihon Rinsho; 1992 Feb; 50(2):237-43. PubMed ID: 1535386
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of a bleeding disorder characterized by platelet unresponsiveness to thromboxane A2.
Fuse I; Higuchi W; Aizawa Y
Semin Thromb Hemost; 2000; 26(1):43-5. PubMed ID: 10805281
[TBL] [Abstract][Full Text] [Related]
11. Hypersensitivity to thromboxane A2 in cholesterol-rich human platelets.
Tomizuka T; Yamamoto K; Hirai A; Tamura Y; Yoshida S
Thromb Haemost; 1990 Dec; 64(4):594-9. PubMed ID: 2150728
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2 activates phospholipase C in astrocytoma cells via pertussis toxin-insensitive G-protein.
Nakahata N; Matsuoka I; Ono T; Nakanishi H
Eur J Pharmacol; 1989 Mar; 162(3):407-17. PubMed ID: 2545456
[TBL] [Abstract][Full Text] [Related]
13. Influx of extracellular calcium and agonist-coupling appear essential for the activation of thromboxane A2-dependent phospholipase A2 in human platelets.
Murthy M; Rao GH; Robinson P; Reddy S
Prostaglandins Leukot Essent Fatty Acids; 1995 Jul; 53(1):31-9. PubMed ID: 7675820
[TBL] [Abstract][Full Text] [Related]
14. Functional reconstitution of platelet thromboxane A2 receptors with Gq and Gi2 in phospholipid vesicles.
Ushikubi F; Nakamura K; Narumiya S
Mol Pharmacol; 1994 Nov; 46(5):808-16. PubMed ID: 7969066
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation by tetraprenol via stimulation of phospholipase A2 action.
Nakano T; Matsumoto S; Hanasaki K; Arita H
J Biochem; 1989 Nov; 106(5):887-93. PubMed ID: 2533198
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the platelet thromboxane A2 (TXA2) receptor in patients characterized by the absence of TXA2-induced platelet aggregation despite normal TXA2 binding activity.
Higuchi W; Fuse I; Hattori A; Aizawa Y
Thromb Haemost; 1999 Nov; 82(5):1528-31. PubMed ID: 10595649
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of a dominantly inherited bleeding disorder with impaired platelet responses to thromboxane A2.
Okuma M; Hirata T; Ushikubi F; Kakizuka A; Narumiya S
Pol J Pharmacol; 1996; 48(1):77-82. PubMed ID: 9112632
[TBL] [Abstract][Full Text] [Related]
18. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
19. Ketamine suppresses platelet aggregation possibly by suppressed inositol triphosphate formation and subsequent suppression of cytosolic calcium increase.
Nakagawa T; Hirakata H; Sato M; Nakamura K; Hatano Y; Nakamura T; Fukuda K
Anesthesiology; 2002 May; 96(5):1147-52. PubMed ID: 11981155
[TBL] [Abstract][Full Text] [Related]
20. Pertussis toxin-sensitive GTP-binding proteins may regulate phospholipase A2 in response to thrombin in rabbit platelets.
Kajiyama Y; Murayama T; Nomura Y
Arch Biochem Biophys; 1989 Oct; 274(1):200-8. PubMed ID: 2505676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]